A Multicentre, Observational Study to Evaluate the Real-World Outcomes of Palynziq® (Pegvaliase) in Subjects with Phenylketonuria (OPAL) First published 19/07/2021 Last updated 20/06/2024 EU PAS number:EUPAS41426 Study Ongoing